methylene blue has been researched along with End Stage Liver Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Armour, S; Ritter, MJ; Smith, BB; Warner, MA | 1 |
1 other study(ies) available for methylene blue and End Stage Liver Disease
Article | Year |
---|---|
Cardiopulmonary Bypass Ultrafiltrate Discoloration After Hydroxocobalamin Administration.
Topics: Adult; Blood Loss, Surgical; Cardiopulmonary Bypass; Color; Diagnosis, Differential; End Stage Liver Disease; Enzyme Inhibitors; Heart Valve Diseases; Heart Valve Prosthesis Implantation; Humans; Hydroxocobalamin; Male; Methylene Blue; Nitric Oxide Synthase; Pharmaceutical Solutions; Postoperative Complications; Ultrafiltration; Vasoconstrictor Agents; Vasoplegia | 2019 |